跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
克拉霉素干混悬剂 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Clarithromycin for Suspension
Approved
化学药品
Clarithromycin for Suspension
ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Nov 14, 2023
Approval ID
8VIZTAO0wdZ
Company
ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
Type
化学药品
Approval Details
Approval Id
8VIZTAO0wdZ
Approval Number
国药准字HJ20160416
Generic Name
克拉霉素干混悬剂
Generic Name En
Clarithromycin for Suspension
Drug Type
化学药品
Dosage Form
口服混悬剂
Strength
125mg/5ml
Reg Date
2023-11-14
Expired Date
2028-07-12
Company Name
ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
Production Company Name
ABBVIE SRL
Company Detail Path
/organization/abbott-laboratories-singapore-private-limited
Production Company Detail Path
/organization/abbvie-srl
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 14, 2023
Approval ID
8VIZTAO0wdZ
Type
化学药品
Back to NMPA Approvals